Access cutting-edge cystic fibrosis treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.
Access cystic fibrosis specialists in Minneapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cystic fibrosis treatment provided free
A double-blind, active-controlled, multiple-ascending dose, safety study of aerosolized RSP-1502 in subjects with cystic fibrosis Pseudomonas aeruginosa lung infection.
Sponsor: Respirion Pharmaceuticals Pty Ltd
Check if you qualify for this cystic fibrosis clinical trial in Minneapolis, MN
If you're searching for cystic fibrosis treatment options in Minneapolis, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cystic fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.